General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Biosense-Webster(SIGNIFICANT), Medtronic-Cryocath(SIGNIFICANT), Boston Scientific(SIGNIFICANT), Impulse Dynamics(SIGNIFICANT), Philips(MODEST), Abbott Inc(SIGNIFICANT), CardioNXT(SIGNIFICANT), AFTx(SIGNIFICANT), Biotronik(SIGNIFICANT), AtriAN(SIGNIFICANT), Fire1(SIGNIFICANT), CoreMap(SIGNIFICANT), Novo Nordisk Inc.(MODEST), Cairdac(SIGNIFICANT), Novartis Corporation(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Surecor(SIGNIFICANT), kardium(SIGNIFICANT), Newtrace(SIGNIFICANT), CoRISMA(SIGNIFICANT), Restore Medical(SIGNIFICANT), Dinova Hangzhou Nuomao Medtech, Ltd(SIGNIFICANT), Intershunt(SIGNIFICANT), HRT(SIGNIFICANT), CardiaCare(SIGNIFICANT), APN Health(SIGNIFICANT), Biostar Ventures(SIGNIFICANT), Soundcath(SIGNIFICANT), DRS Vascular(SIGNIFICANT), Vizaramed(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Manual Surgical Sciences, Inc(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Acutus Medical(SIGNIFICANT), Affera Inc(SIGNIFICANT), Autonomix Inc(SIGNIFICANT), Biosig Inc(SIGNIFICANT), Circa(SIGNIFICANT), Farapulse(SIGNIFICANT), Valcare(SIGNIFICANT), Medlumics(SIGNIFICANT), Corvia Medical(SIGNIFICANT), EP Dynamics(SIGNIFICANT), Javelin(SIGNIFICANT), Axon(SIGNIFICANT), East End Medical(SIGNIFICANT), Newpace(SIGNIFICANT), Laminar(SIGNIFICANT), Field Medical(SIGNIFICANT), Focused Therapeutics(SIGNIFICANT), Anumana(SIGNIFICANT), Atacor(SIGNIFICANT), Aquaheart(SIGNIFICANT), Cardiofocus(SIGNIFICANT), Nyra Medical(SIGNIFICANT), Ablacon-Cortex(SIGNIFICANT), Append Medical(SIGNIFICANT), Backbeat - Oracle Health(SIGNIFICANT), LuxMed(SIGNIFICANT), Nuvera (JNJ-Medtech)(SIGNIFICANT), Pulse Biosciences(SIGNIFICANT), Sirona Medical(SIGNIFICANT)

View Full Disclosure